Analyzing Pfizer's COVID-19 vaccine PR strategy / Kelsey Lawrence.
This case examines the public relations and communications strategy of pharmaceutical giant Pfizer, which is expected to launch a Covid-19 vaccine after announcing successful trials in the fall of 2020. With a vaccine coming amid a highly fraught political moment in the United States, Pfizer's...
Saved in:
| Main Author: | |
|---|---|
| Format: | Ebook |
| Language: | English |
| Published: |
London :
SAGE Publications: SAGE Business Cases Originals,
2021.
|
| Series: | SAGE business cases.
|
| Subjects: | |
| Online Access: | SAGE |
| Summary: | This case examines the public relations and communications strategy of pharmaceutical giant Pfizer, which is expected to launch a Covid-19 vaccine after announcing successful trials in the fall of 2020. With a vaccine coming amid a highly fraught political moment in the United States, Pfizer's messaging has attempted to distance the company--and its vaccine research--from the Trump administration's Operation Warp Speed initiative, despite the company's collaboration with the administration to help facilitate eventual distribution of the vaccine. The case asks students to assess Pfizer's messaging and discuss the strategic benefits and pitfalls of the company's effort to distance itself from the sitting president. |
|---|---|
| Physical Description: | 1 online resource : illustrations. |
| Bibliography: | Includes bibliographical references. |
| ISBN: | 1529770696 9781529770698 |